Regeneron Pharmaceuticals

Appeals Court Revives Regeneron Pharmaceuticals’ Lawsuit Against Novartis

A United States 2nd U.S. Circuit Court of Appeals in Manhattan on Monday, March 18, 2024, revived the antitrust lawsuit filed against Novartis by Regeneron Pharmaceuticals.